Preliminary investigation of bilateral internal iliac artery ligation and anterior tumor separation through laparoscopy before posterior resection of a giant sacral tumor

Zhang, Ying; Chen, Wugui; Yang, Sizhen; Qiu, Hao; Sun, Jing; Hu, Xu; Liao, Tongquan; Yang, Lei; Liu, Yugang; Chu, Tongwei

doi:10.1016/j.suronc.2020.03.002

Cited by 2 publications

(10 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 2015 ZHANG ET AL. [6] PRELIMINARY INVESTIGATION OF BILATERAL INTERNAL ILIAC ARTERY LIGATION AND ANTERIOR TUMOR SEPARATION THROUGH LAPAROSCOPY BEFORE POSTERIOR RESECTION OF GIANT SACRAL TUMOR 2020 ZILELI ET AL. [8] SURGICAL TREATMENT OF PRIMARY SACRAL TUMORS: COMPLICATIONS ASSOCIATED WITH SACRETOMY 2003 LI ET AL.…”

Section: Resultsmentioning

confidence: 99%

“…The occurrence of pain and neurological disorders, which are more severe symptoms, are usually caused by disc protrusion [1] , [5] . Owing to their slow progression, sacral lesions are usually already large at the time of diagnosis and are sometimes inoperable, making surgical treatment challenging and causing hesitation in making clinical decisions [1] , [6] .…”

Section: Introductionmentioning

confidence: 99%

“…Therefore, an understanding of the anatomy of this complex region is necessary to minimize the occurrence of sequelae from the procedure [1] , [8] , [9] . In addition, the surgical margin should not be compromised to preserve structures, since disease-free survival requires tumor-free margins [6] , [10] .…”

Section: Introductionmentioning

confidence: 99%

“…The choice of surgical technique for sacrectomy depends on the size, location, and histological type of the tumor. Sacrectomy can be performed using an anterior-only, anterior and posterior, or a posterior-only approach [6] , [11] , [12] . Margin involvement and intralesional curettage can increase the rate of recurrence and reduce the survival rate of patients.…”

Section: Introductionmentioning

confidence: 99%

“…Margin involvement and intralesional curettage can increase the rate of recurrence and reduce the survival rate of patients. Therefore, wide lesion resection is the most effective technique for controlling and reducing the risk of local recurrence of primary sacral tumors and prolonging a patient's life [6] , [13] , [14] , [15] , [16] , [17] .…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Analysis of morbidity and mortality in patients with primary bone tumors who underwent sacrectomy: A systematic review

Silva

Martins²,

Garofo³

et al. 2022

Journal of Bone Oncology

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Analysis of morbidity and mortality in patients with primary bone tumors who underwent sacrectomy: A systematic review

Silva

Martins²,

Garofo³

et al. 2022

Journal of Bone Oncology

View full text Add to dashboard Cite

Clinical Outcome after Surgical Treatment of Sacral Chordomas: A Single-Center Retrospective Cohort of 27 Patients

Goumenos,

Kakouratos,

Trikoupis

et al. 2024

Cancers

View full text Add to dashboard Cite

Introduction: The aims of our study were (1) to determine disease-specific and disease-free survival after the en-bloc resection of sacral chordomas and (2) to investigate potential risk factors for tumor recurrence and major postoperative wound-related complications. Methods: We retrospectively analyzed 27 consecutive patients with sacral chordomas who were surgically treated in our institution between 2004 and 2022. Three patients (11.1%) had a recurrent tumor and four patients (14.8%) had history of a second primary solid tumor prior to or after their sacral chordoma. A combined anterior and posterior approach, colostomy, plastic reconstruction, and spinopelvic instrumentation were necessitated in 51.9%, 29.6%, 37%, and 7.4% of cases, respectively. The mean duration of follow-up was 58 ± 41 months (range= 12–170). Death-related-to-disease, disease recurrence, and major surgical site complications were analyzed using Kaplan–Meier survival analysis, and investigation of the respective risk factors was performed with Cox hazard regression. Results: The estimated 5-year and 10-year disease-specific survival was 75.3% (95% CI = 49.1–87.5%) and 52.7% (95% CI = 31–73.8%), respectively. The estimated 1-year, 5-year, and 10-year disease-free survival regarding local and distant disease recurrence was 80.4% (95% CI = 60.9–91.1%), 53.9% (95% CI = 24.6–66.3%), and 38.5% (95% CI = 16.3–56.2%), respectively. The mean survival of the recurred patients was 61.7 ± 33.4 months after their tumor resection surgery. Conclusions: Despite the high relapse rates and perioperative morbidity, long-term patient survival is not severely impaired. Positive or less than 2 mm negative resection margins have a significant association with disease progression.

show abstract

Preliminary investigation of bilateral internal iliac artery ligation and anterior tumor separation through laparoscopy before posterior resection of a giant sacral tumor

Cited by 2 publications

References 27 publications

Analysis of morbidity and mortality in patients with primary bone tumors who underwent sacrectomy: A systematic review

Analysis of morbidity and mortality in patients with primary bone tumors who underwent sacrectomy: A systematic review

Clinical Outcome after Surgical Treatment of Sacral Chordomas: A Single-Center Retrospective Cohort of 27 Patients

Contact Info

Product

Resources

About